机构:[1]Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China首都医科大学附属北京友谊医院[2]Department of Ophthalmology,Beijing TongRen Hospital,Capital Medical University,Beijing 100732,China临床科室眼科首都医科大学附属北京同仁医院首都医科大学附属同仁医院眼科(未分亚科)[3]Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China首都医科大学附属北京友谊医院[4]Department of Endocrinology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China首都医科大学附属北京友谊医院
Thyroid-associated ophthalmopathy (TAO) is an autoimmune disease. Studies showed that T helper 1 (Th1), Th2, and Th17 cells play important roles in the pathology of TAO. Tim-3 and its only known ligand Galectin-9 (Gal-9) is related to the suppression of Th1 and Th17 cytokine secretion. This study aims to investigate the role of Tim3/Gal-9 in the inflammatory response of TAO. In this study, the levels of Tim3, Gal-9, and cytokines of Thl (TNF-alpha and IFN-gamma), Th2 (IL-4), and Th17 (IL-17) cells were analyzed in the blood samples of TAO patients and healthy controls as well as in orbital fibroblasts. Tim3 overexpression and Gal-9 neutralizing antibody were used in TAO and LPS-stimulated control orbital fibroblasts to further investigate the role and mechanism of Tim3/Gal-9 on the inflammation of TAO. We found Tim3 and Gal-9 expression was significantly downregulated in TAO patients and further lower in active TAO than inactive TAO or controls. Thl, Th2, and Th17 cytokines were all increased in TAO patients. Thl and Th17 cytokines were higher in active TAO patients than in inactive TAO patients, while Th2 cytokines were enhanced in inactive TAO. Tim3 overexpression decreased the levels of Thl and Th17 cytokines, but not Th2 cytokine in TAO or LPS-stimulated control orbital fibroblasts. These effects were abrogated by Gal-9 neutralizing antibody. Moreover, Tim3 reduced the levels of p-Akt and p-p65 in TAO or LPS-induced control orbital fibroblasts that were reversed by Gal-9 blocking. In conclusion, Tim3/Gal-9 alleviates the inflammation of TAO patients via suppressing Akt/NF-kappa B signaling pathway. (C) 2017 Elsevier Inc. All rights reserved.
第一作者机构:[1]Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
通讯作者:
通讯机构:[2]Department of Ophthalmology,Beijing TongRen Hospital,Capital Medical University,Beijing 100732,China[*1]Department of Ophthalmology,Beijing TongRen Hospital,Capital Medical University,No.1 Dongjiaominxiang,Dongcheng District,Beijing 100732,China
推荐引用方式(GB/T 7714):
Luo Li-Hua,Li Dong-Mei,Wang Yan-Ling,et al.Tim3/galectin-9 alleviates the inflammation of TAO patients via suppressing Akt/NF-kB signaling pathway[J].BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.2017,491(4):966-972.doi:10.1016/j.bbrc.2017.07.144.
APA:
Luo, Li-Hua,Li, Dong-Mei,Wang, Yan-Ling,Wang, Kang,Gao, Li-Xin...&Guo, Hong.(2017).Tim3/galectin-9 alleviates the inflammation of TAO patients via suppressing Akt/NF-kB signaling pathway.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,491,(4)
MLA:
Luo, Li-Hua,et al."Tim3/galectin-9 alleviates the inflammation of TAO patients via suppressing Akt/NF-kB signaling pathway".BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 491..4(2017):966-972